Efficacy of the perioperative opioid-sparing anesthesia based on bundle care on quality of patients' recovery in video-assisted thoracoscopic surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068071

Enrollment

Unknown

Registered

2023-02-06

Start date

2023-02-06

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

opoid-spare anesthesia, OSA:perioperative Intercostal nerve block

conventional anesthesia, CA:conventional anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years; 2. ASA I-III; 3. Voluntary signed informed consent form; 4. Expected to be extubated after surgery.

Exclusion criteria

Exclusion criteria: 1. Local anesthetic allergy; 2. Have nerve block contraindications, such as coagulation abnormalities, puncture site infection; 3. With severe heart disease (coronary heart disease), hypertension, liver disease; 4. Renal insufficiency (estimated glomerular filtration rate <15mL/min/1.73m^2); 5. Chronic pain or chronic opioid use history and mental illness; 6. Pregnant or lactation women; 7. Participate in other clinical trials.

Design outcomes

Primary

Measure	Time frame
Quality of Recovery Score-15;	—

Secondary

Measure	Time frame
numerical rating scale;First pain needs time;Richmond Agitation and sedation Score (RASS);Sleep quality score;	—

Countries

China

Contacts

Public ContactPeng Liang

West China Hospital of Sichuan University

liangpengwch@scu.edu.cn+86 189 8060 2201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026